Effect of Vasopressin on Hemodynamics in Patients With Refractory Cardiogenic Shock Complicating Acute Myocardial Infarction

This publication has 10 references indexed in Scilit:

• Effects of intravenous arginine vasopressin on epicardial coronary artery cross sectional area in a swine resuscitation model
  Resuscitation, 2005
• Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
  Journal of the American College of Cardiology, 2004
• A Comparison of Vasopressin and Epinephrine for Out-of-Hospital Cardiopulmonary Resuscitation
  New England Journal of Medicine, 2004
• Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology
  Critical Care, 2004
• LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock A prospective randomized study
  Published by Oxford University Press (OUP) ,2003
• Arginine Vasopressin in Advanced Vasodilatory Shock
  Circulation, 2003
• The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series
  Intensive Care Medicine, 2001
• Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide
  European Journal of Pharmacology, 1998
• Opposing Effects of Plasma Epinephrine and Norepinephrine on Coronary Thrombosis In Vivo
  Circulation, 1995
• Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels.
  Circulation, 1991